AUROPHARMA.NS Overview

Company Profile

Related stocks

CIPLA.NS • India

CIPLA LTD

1,301 INR

10.86B USD 1Y -14%

LUPIN.NS • India

LUPIN LIMITED

1,956.5 INR

9.24B USD 1Y -0.1%

RDY • India

Dr. Reddy's Laboratories Ltd

12.48 USD

10.4B USD 1Y -12.8%

DRREDDY.NS • India

DR. REDDY S LABORATORIES

1,197 INR

10.3B USD 1Y -3.9%

LAURUSLABS.NS • India

LAURUS LABS LIMITED

2,036.6 INR

11.37B USD 1Y +135.4%

ABBOTINDIA.NS • India

ABBOTT INDIA LIMITED

26,000 INR

5.71B USD 1Y -14.5%

MANKIND.NS • India

MANKIND PHARMA LIMITED

2,368.5 INR

10.11B USD 1Y -3.1%

ZYDUSLIFE.NS • India

ZYDUS LIFESCIENCES LTD

1,117.5 INR

11.52B USD 1Y +12.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

29.4% p.a.

Max Drawdown (5Y)

-45.2%

Sharpe Ratio (5Y)

0.55

Beta Factor

0.03

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (29.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -65.6% in the extended horizon.